A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma

Lung adenocarcinoma (LUAD) is a remarkably heterogeneous and aggressive disease with dismal prognosis of patients. The identification of promising prognostic biomarkers might enable effective diagnosis and treatment of LUAD. Aberrant activation of epithelial-mesenchymal transition (EMT) is required...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yimeng, Wang, Xin, Zhang, Lei, Liu, Wei, Ning, Jinfeng, Gu, Ruixue, Cui, Yaowen, Cai, Li, Xing, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521574/
https://www.ncbi.nlm.nih.gov/pubmed/36185284
http://dx.doi.org/10.3389/fonc.2022.974614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521574/
https://www.ncbi.nlm.nih.gov/pubmed/36185284
http://dx.doi.org/10.3389/fonc.2022.974614

Ejemplares similares